¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"active aldehyde theory"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • active marrow
    Ȱ¼º°ñ¼ö
  • active material
    Ȱ¼º¹°Áú, Ȱ¼ºÀç
  • active movement
    ´Éµ¿¿îµ¿
  • active negativism
    Àû±Ø°ÅºÎÁõ
  • active oxygen
    Ȱµ¿»ê¼Ò, Ȱ¼º»ê¼Ò
  • active phase
    Ȱ¼º±â
  • active placebo
    Ȱ¼º¼ÓÀÓ¾à
  • active prosthesis
    Ȱµ¿ÀÇÁö, ´Éµ¿ÀÇÁö
  • active shielding
    ´Éµ¿Â÷Æó
  • active shimming
    ´Éµ¿º¸Á¤
  • active site
    Ȱ¼ººÎÀ§
  • active transport
    ´Éµ¿¿î¹Ý
  • active treatment
    Àû±ØÄ¡·á
  • active tuberculosis
    Ȱµ¿°áÇÙ
  • chronic active hepatitis
    ¸¸¼ºÈ°µ¿°£¿°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • MR active nuclei
    ÀÚ±â°ø¸íȰ¼ºÇÙ
  • alternation theory
    ±³¹ø¼³
  • backward failure theory
    ÈĹæÀå¾Ö¼³
  • centrifugal sprouting theory
    ¿ø½É½ÏÆ·¿ò¼³, ¿ø½É¹ß¾Æ¼³
  • clonal selection theory
    Ŭ·Ð¼±Åü³
  • conditioning theory
    Á¶°ÇÈ­ÀÌ·Ð
  • convergence-projection theory
    ÆøÁÖÅõ»ç¼³
  • corpuscular theory
    ÀÔÀÚ¼³
  • countercurrent theory
    ¿ª·ù¼³, ´ëÇâ·ù¼³
  • cross-linking theory
    ±³Â÷¿¬°üÀÌ·Ð
  • developmental theory
    ¹ß´ÞÀÌ·Ð
  • dichotomous theory
    À̺йýÇм³
  • dipole theory
    ½Ö±Ø¼³
  • double-axis theory
    ÀÌÁßÃàÀÌ·Ð
  • enzyme trace substance theory
    È¿¼ÒÈçÀû¹°¼³
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • active gradient shielding
    ´Éµ¿ °æ»ç Â÷Æó
  • active hydrogen
    Ȱ¼º¼ö¼Ò(¡­â©áÈ).
  • active imagination
    Àû±ØÀû »ó»ó
  • active immunity
    ´Éµ¿¸é¿ª(ÒöÔÑØóæ¹).
  • active immunization
    ´Éµ¿¸é¿ª(È­)(ÊÙÌ´).
  • active immunization
    ´Éµ¿¸é¿ª¹ý, ´Éµ¿¸é¿ªÁ¶Ä¡
  • active incorporative mode
    Àû±ØÀû ÇÔÀÔ ¾ç½Ä
  • active marrow
    Àû°ñ¼ö.
  • active material
    Ȱ¼º¹°Áú(üÀàõÚªòõ).
  • active movement
    ´Éµ¿¿îµ¿(ÒöÔÑê¡ÔÑ)
  • active negativism
    Àû±Ø¼º °ÅÀýÁõ.
  • active oxygen
    Ȱ¼º»ê¼Ò(üÀàõß«áÈ).
  • active shielding
    ´Éµ¿ Â÷Æó
  • active shimming
    ´Éµ¿ º¸Á¤
  • active site
    Ȱ¼ºÀÚ¸®.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • active treatment
    Á÷Á¢Ä¡·á, Àû±Ø¿ä¹ý(îÝпèþÛö).
  • active tuberculosis
    Ȱµ¿¼º °áÇÙ(Áõ)(üÀÔÑàõÌ¿ú·ñø).
  • artificial active immunity
    Àΰø´Éµ¿¸é¿ª.
  • assisted active exercise
    º¸Á¶´Éµ¿¿îµ¿.
  • assisted active exercise
    º¸Á¶´Éµ¿¿îµ¿.
  • cationic active agent
    ¾çÀÌ¿ÂȰ¼ºÁ¦(åÕ¡­üÀàõð¥).
  • chronic active hepatitis
    ¸¸¼ºÈ°µ¿¼º °£¿°(¡­ÊÜæú).
  • chronic active hepatitis
    ¸¸¼º Ȱµ¿¼º °£¿°
  • disinfectant, surface-active
    °è¸éȰ¼º¼Òµ¶Á¦
  • hepatitis,chronic active
    ¸¸¼ºÈ°µ¿¼º(Ø·àõüÀÔÑàõ)
  • immunity, active
    ´Éµ¿¸é¿ª
  • immunization, active
    ´Éµ¿¸é¿ª, ´Éµ¿¸é¿ªÁ¶Ä¡
  • metabolically active stone
    ´ë»ç(¼º)Ȱ¼º(È­)°á¼®
  • positive placebo =active p.
    ¾ç¼ºÇö󼼺¸, Ç¥Áؾà(øöñÞå·).
  • probe electrode =active e.
    Ž»öÀü±Ø.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • active methyl
    Ȱ¼º(üÀàõ)¸ÞÆ¿
  • active patch
    Ȱ¼º(üÀàõ)ÆÖÄ¡
  • active phosphate
    Ȱ¼ºÀλ꿰 (üÀàõ ×òß«ç¤)
  • active phospholipid
    Ȱ¼ºÀÎÁöÁú (üÀàõ×òò·òõ)
  • active pyrophosphate
    Ȱ¼º(üÀàõ)ÇÇ·ÎÀλ꿰 (×òß«ç¤)
  • active pyruvate
    Ȱ¼º(üÀàõ)ÆÄÀÌ·çºê»ê¿° (ß«ç¤)
  • active site
    Ȱ¼º(üÀàõ)ÀÚ¸®
  • active site-directed irreversible inhibitor
    Ȱ¼º(üÀàõ)ÀÚ¸®ÁöÇâÀû ºÒ°¡¿ªÀúÇØÁ¦(ò¦ú¾îÜÝÕʦæ½îÁúªð¥)
  • active sulfate
    Ȱ¼ºÈ²»ê¿° (üÀàõüÜß«ç¤)
  • active translocation
    Ȱ¼ºÀüÀ§ (üÀàõï®êÈ)
  • active transport
    ´Éµ¿¼ö¼Û (ÒöÔÑâÃáê)
  • flexible active site
    °¡º¯(ʦܨ) Ȱ¼º(üÀàõ)ÀÚ¸®
  • gradient-coupled active transport
    ±¸¹è(ÎþÛÕ) ¦Áø ´Éµ¿¼ö¼Û(ÒöÔÑâÃáê)
  • primary active transport
    ÀÏÂ÷ ´Éµ¿¼ö¼Û(ìéó­ÒöÔÑâÃáê)
  • secondary active transport
    ÀÌÂ÷ ´Éµ¿¼ö¼Û(ì£ó­ÒöÔÑâÃáê)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
AF abnormal frequency; acid-fast; adult female; afebrile; aflatoxin; albumin-free; albumose-free; aldeh...
ALDH aldehyde dehydrogenase
ALR aldehyde reductase
AT-PAS aldehyde-thionine-periodic acid Schiff [test]
TAF albumose-free tuberculin [Ger. Tuberculin Albumose frei]; tissue angiogenesis factor; toxin-antitoxi...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
ALDH1 Aldehyde dehydrogenase 1
ALDH2 Aldehyde dehydrogenase-2
AO Aldehyde oxidase
ALR Aldehyde reductase
BADH Betaine aldehyde dehydrogenase
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • alternation theory
    ±³¹ø¼³
  • apposition theory
    ºÎÂø¼³
  • biophysical theory
    »ý¹°¸®Çм³
  • Burnet's clonal selection theory
    ?
  • chemo-parasitic theory
    È­ÇÐ ¼¼±Õ¼³
    ¿ì½ÄÀÇ ¿øÀο¡ °üÇÏ¿© Miller°¡ ¼¼¿î Çм³. ¿ì½ÄÀÇ ¹ß»ýÀº Ä¡¾ÆÀÇ ÁÖü¸¦ ÀÌ·é ¼®È¸¿°ÀÇ Å»È¸À̰í, ±× ¿øÀÎÀÌ µÇ´Â »êÀº À½½Ä¹° Áß¿¡ Æ÷ÇԵǾî Àִ ź¼öÈ­¹°À» ±¸°­³»ÀÇ ¼¼±ÕÀÌ ¹ßÈ¿ÇϹǷΠÀÎÇØ¼­ »ý±â´Â À¯±â»êÀ̶ó´Â °¡¼³À» ¼¼¿ü´Ù. Miller´Â ¿ì½Ä Á¶Á÷À» È­ÇÐÀûÀ¸·Î ºÐ¼®ÇÏ°í ±×°Í¿¡ Æ÷ÇԵǾî ÀÖ´Â Ä®½·°ú À¯±âÁúÀÇ ¾çÀÌ ÀÌ»óÇÏ°Ô °¨¼ÒµÇ¾î ÀÖ´Â °ÍÀ» ¾Ë¾Ò´Ù. Áï ¿ì½Ä Ç¥ÃþºÎÀÇ ¿¬È­ »ó¾ÆÁúÀº Á¤»óÀÇ Ä¡Áú¿¡ ºñÇÏ¿© 92.5%ÀÇ Ä®½·°ú 39.4%ÀÇ À¯±âÁúÀÌ ¼Õ½ÇµÇ¾î ÀÖ°í ¿ì½Ä ½ÉºÎ¿¡¼­´Â 22.0%ÀÇ Ä®½· »ó½ÇÀ» ³ªÅ¸³Â´Ù. ±×·¯¹Ç·Î ±×´Â ½ÇÇèÀ» ÅëÇÏ¿© Ä¡¾Æ¿¡ À¯±â»ê°ú »§°¡·ç¸¦ ¼¯Àº °ÍÀ» ¾È¿¡ ºÙ¿© ³õÀº °á°ú, »ýÈ­ÇÐÀûÀ¸·Î ¿ì½Ä°ú ºñ½ÁÇÑ »óŰ¡ ÀϾ´Â °ÍÀ» ±ú´Ý°í, ¿ì½ÄÀÇ °æ¿ì´Â »êÀÌ Å« ÀÛ¿ëÀ» Çϸç, ±× À¯±â»êÀº »ó¾Æ¼¼°ü³»³ª Ä¡¾ÆÀÇ Ç¥¸é¿¡¼­ º¼ ¼ö ÀÖ´Â ´ÙÁ¾ ´Ù¾çÀÇ ¼¼±Õ¿¡ ÀÇÇØ¼­ À½½Ä¹° Àܻ翡 Æ÷ÇÔµÈ Åº¼öÈ­¹°ÀÇ ¹ßÈ¿¿¡ ÀÇÇÑ °ÍÀ̶ó°í »ý°¢ÇÏ¿´À¸³ª ±×´Â ±× ÁÖ¿ªÀ» ¸ÃÀº ¼¼±ÕÀÌ ¹«¾ùÀΰ¡´Â ¾ð¸íÇÏÁö ¾Ê¾Ò´Ù. ÀÌ È­ÇÐ ¼¼±Õ¼³Àº Èļ¼±îÁö °­ÇÑ ¿µÇâÀ» ¹ÌÄ¡°í ¿ì½ÄÀÇ ¼¼±ÕÇÐÀû ¿¬±¸ÀÇ ÁÖ·ù¸¦ ÀÌ·ç¾î ¿Ô´Ù.
  • clonal selection theory
    Ŭ·Ð ¼±Åü³
  • Combinational theory
    Á¶ÇÕ¼³
    Ç×ü ¹ßÇöÀÇ ´Ù¾ç¼ºÀ» ¼ø¿­ Á¶ÇÕ¿¡¼­ ±¸ÇÏ´Â Çм³.
  • contagium theory
    Àü¿°¼³, °¨¿°¼³
  • doublet theory
    ÀÌÁß±Ø ¼³
  • Ehrlich`s side chain theory
    ¿¡¸¦¸®È÷ÀÇ Ãø¼â¼³
    Ç×ü »ý»ê ±âÀü¿¡ ´ëÇÏ¿© Á¦¾ÈµÈ °¡¼³ÀÇ Çϳª. ¸ðµç ü ¼¼Æ÷ Ç¥¸é¿¡´Â Ãø¼â¶ó°í ÇÏ´Â ¼ö¿ëü°¡ ÀÖ°í, À̰Ϳ¡ ´ëÀÀÇÏ´Â Ç׿øÀÌ °áÇÕÇϸé Ȱ¼ºÈ­ µÇ°í, Ãø¼â°¡ °úÀ× »ý»êµÇ¾î Ç×ü·Î¼­ Ç÷·ù ¼Ó¿¡ ¹æÃâµÈ´Ù°í ÇÏ´Â »ý°¢. Ç×ü »ý»êÀÇ ¼±Åü³ÀÇ ÃÖÃÊÀÇ °ÍÀÌ´Ù.
  • epoigenetic theory
    Èļº¼³
  • error accumulation theory
    ¿ÀÂ÷ ´©Àû¼³
    ³ëÈ­ÀÇ ¿øÀÎÁõ.
  • evolution theory
    ÁøÈ­·Ð
  • fluid mosaic theory
    À¯µ¿ ¸ðÀÚÀÌÅ© ¼³
  • ionic theory
    À̿¼³
    Àü·ù´Â ÀÌ¿ÂÀ» ¿î¹ÝÇÏ´Â ¿ªÇÒ¸¸À» Çϸç, Àü·ù¿Í´Â °ü°è¾øÀÌ ÀüÇØÁú ¿ë¾×Àº Ç×»ó ÀÏÁ¤ÇÑ Àü¸®µµ·Î¼­ Àü¸®ÇÏ¿© ÀÖ´Ù´Â ¼³.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
cinnamic aldehyde 3-phenylpropenal;chief constituent of cinnamon oil.
Synonym: cinnamic aldehyde.
(05 Mar 2000)
molybdenum-iron protein aldehyde oxidoreductase <enzyme> Related to xanthine oxidase; isolated from desulfovibrio gigas
Registry number: EC 1.2.7.-
Synonym: mop protein
(26 Jun 1999)
salicylic aldehyde salicyl aldehyde
pyruvic aldehyde CH3-CO-CHO; Pyruvaldehyde;the aldehyde of pyruvic acid; an intermediate of carbohydrate metabolism in certain organisms.
Synonym: pyruvic aldehyde.
Methylglyoxal bis(guanylhydrazone), 1,1'-[(methylethanediylidene)dinitrilo]diguanidine;an antineoplastic agent.
(05 Mar 2000)
sugar aldehyde A sugar that contains an internal acetal.
(05 Mar 2000)
ketone-aldehyde mutase <enzyme> An enzyme that catalyses the interconversion of methylglyoxal and lactate, with glutathione serving as a coenzyme.
Chemical name: S-Lactoyl-glutathione methylglyoxal-lyase (isomerizing)
Registry number: EC 4.4.1.5
(12 Dec 1998)
formic aldehyde <chemical> Commonly used fixative and antibacterial agent. As a fixative it is cheap and tends to cause less denaturation of proteins than does glutaraldehyde, particularly if used in a well buffered solution (buffered formalin, formal saline).
Old formaldehyde solutions usually contain cross linking contaminants and it is therefore often preferable to used a formaldehyde generating agent such as paraformaldehyde. Formalin fumes, particularly in conjunction with hydrochloric acid vapour, are potently carcinogenic.
(20 Jun 2000)
active Characterised by action, not passive, not expectant.
(18 Nov 1997)
active acetate <enzyme> Condensation product of coenzyme A and acetic acid, symbolised as CoAS~COCH3; intermediate in transfer of two-carbon fragment, notably in its entrance into the tricarboxylic acid cycle and in fatty acid synthesis.
This coenzyme plays a huge role in intermediary metabolism, in which cells synthesise, break down or use nutrient molecules for energy production, growth, etc.
Acetyl-coenzyme A synthase is found in bacteria and plants and catalyses the reaction in which acetate enters metabolic pathways and forms acetyl-coenzyme A.
Synonym: acetyl-coenzyme A, active acetate.
(05 Mar 2000)
active anaphylaxis Reaction following inoculation of antigen in a subject previously sensitised to the specific antigen, in contrast to passive anaphylaxis.
(05 Mar 2000)
active biomass <cell biology> The amount of a given culture that is actively growing.
(06 May 1997)
active carbon dioxide Activated carbon dioxide, a complex of N-carboxybiotin (biotin + CO2) and an enzyme; the form in which carbon dioxide is added to other molecules in carboxylations; e.g., to methylcrotonyl-CoA to form beta-methylglutaconyl in the catabolism of leucine, and to acetyl-CoA to form malonyl-CoA.
See: acetyl-CoA carboxylase.
(05 Mar 2000)
active caries Microbial-induced lesions of teeth that are increasing in size.
(05 Mar 2000)
active centre The part of a macromolecule at which a substrate or ligand, upon binding, produces biological activity; for an enzyme, this is the catalytic centre, the site on an enzyme that catalyses the reaction.
(05 Mar 2000)
active congestion Congestion due to an increased flow of arterial blood to a part.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á